文献速递关节外科运动医学

评估诊断髂腰肌肌腱病的临床测试

Evaluation of Clinical Tests to Diagnose Iliopsoas Tendinopathy.
PubMed 文献 · Clin Orthop Relat Res · 2025-05-19

该回顾性研究纳入44例因持续性腹股沟疼痛接受透视引导下髂腰肌肌腱注射的患者,评估新型髋外旋-屈曲-天花板(HEC)测试及10项常规体格检查对髂腰肌肌腱病的诊断准确性。HEC测试灵敏度94%、特异度88%、AUC 0.99,被列为最佳诊断测试;作者建议外科医生将HEC测试纳入腹股沟疼痛患者的常规评估。

要点

  • HEC测试诊断髂腰肌肌腱病灵敏度94%、特异度88%、AUC 0.99
  • HEC测试、坐位抗阻屈髋、坐位抗阻髋外旋三项测试满足全部三项「良好」标准
  • Thomas测试、中立位直腿抬高和弹响髋测试被判定为「差」的测试

核心结论

  • HEC测试是诊断髂腰肌肌腱病的准确检查方法,与传统测试相比灵敏度和特异度更高。
  • 作者认为外科医生应考虑将HEC测试纳入腹股沟疼痛患者的常规评估,以提高诊断精确性并优化治疗策略。
  • 未来研究应关注观察者间信度并评估该测试在不同患者群体中的表现。

研究设计与样本

  • 回顾性研究,在一家高手术量的关节置换社区医院进行。
  • 回顾2023年10月至2024年5月连续48例因持续性腹股沟疼痛行透视引导下髂腰肌肌腱注射的病例,排除4例无临床测试数据者,最终纳入44例(平均年龄48±15岁,34%为男性;原生髋52%,全髋关节置换术后48%)。
  • 在透视引导下髂腰肌注射前后进行11项临床测试(包括新型HEC测试和10项常规测试),以特征性腹股沟疼痛改善作为诊断金标准。

主要发现

  • 82%(36/44)的患者注射后疼痛减轻并被诊断为髂腰肌肌腱病,其中HEC测试(6.0±2.1;p<0.001)、坐位抗阻屈髋(5.1±1.3;p<0.001)和SLR in exorotation(4.9±1.4;p<0.001)在浸润后疼痛减轻最具临床意义。
  • HEC测试灵敏度94%、特异度88%、AUC 0.99,高截断值(VAS评分降低5分)优于常规测试。
  • HEC测试、坐位抗阻屈髋和坐位抗阻髋外旋三项测试满足全部三项标准被归为「良好」测试;Thomas测试、中立位SLR和弹响髋测试被判定为「差」的测试。
  • HEC测试在检测髂腰肌肌腱病方面排名最佳,其次是坐位抗阻屈髋、SLR in exorotation和坐位抗阻髋外旋。

关键数值与推荐

  • 「良好」测试需同时满足三项标准:注射后平均VAS疼痛评分显著降低≥3分、疼痛减轻的显著最佳截断值≥4、显著AUC≥0.80。
  • 三项标准均不满足的测试为「差」的测试。
  • 每项临床测试至少30个有效观察值,按每项标准排名,三个排名相加得出总分,总分最低的测试为最佳。

临床怎么用

  • 作者认为外科医生应考虑将HEC测试纳入腹股沟疼痛患者的常规评估,以提高诊断精确性并优化治疗策略。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Diagnosing iliopsoas tendinopathy is challenging because of nonspecific pain patterns and clinical signs overlapping with those of other hip conditions. Although peritendinous anesthetic injections provide the best diagnostic accuracy, they are invasive and resource intensive. Conventional clinical tests largely focus on hip flexion, potentially overlooking the diagnostic contribution of the muscle's secondary function-external rotation. A newly described hip-external rotation-flexion-ceiling (HEC) test combines the primary function (hip flexion) with the secondary function (external rotation) of the iliopsoas, potentially offering enhanced diagnostic reliability. QUESTIONS/PURPOSES: This study aimed to (1) determine the diagnostic accuracy of the HEC test and 10 conventional physical examination tests for iliopsoas-related groin pain; (2) detect "good" and "poor" tests for diagnosing iliopsoas tendinopathy based on three diagnostic performance criteria before and after anesthetic injection (mean pain reduction, optimal cutoff value for pain reduction, and area under the curve [AUC]); and (3) rank all tests, based on the same criteria, to identify the best diagnostic tool. METHODS: In this retrospective study at a high-volume arthroplasty community hospital, we reviewed 48 consecutive fluoroscopy-guided iliopsoas tendon injections performed for persistent groin pain between October 2023 and May 2024. After excluding four patients without any data on the clinical tests performed, a population of 44 participants (mean age 48 ± 15 years; 34% male) remained, which included both native hips (52%) and patients who had undergone THA (48%). Eleven clinical tests-including the novel HEC test and 10 conventional tests (such as resisted hip flexion seated and straight leg raise [SLR] in neutral and external rotation)-were performed before and after a fluoroscopy-guided iliopsoas injection, with an improvement in their characteristic groin pain serving as the diagnostic gold standard. A test was considered "good" if it met all three criteria: (1) a significant mean VAS pain score reduction of ≥ 3 points after injection, (2) a significant optimal cutoff value for pain reduction of ≥ 4, and (3) a significant AUC of ≥ 0.80. A test meeting none of these three criteria was considered "poor." Using the same three criteria, each clinical test with at least 30 valid observations received a ranking position for each criterion, and these three ranks were summed to produce a total score. The test with the lowest total score was deemed the best, followed by the tests with higher scores. Statistical analysis involved estimating sensitivity, specificity, AUC, and optimal cutoff values using receiver operating characteristic curves and the Youden J statistic. RESULTS: In 82% (36 of 44) of patients who experienced pain reduction after injection and who were diagnosed with iliopsoas tendinopathy, the following tests had the most clinically important pain reduction after infiltration: the HEC test (6.0 ± 2.1; p < 0.001), resisted hip flexion (seated) (5.1 ± 1.3; p < 0.001), and SLR in exorotation (4.9 ± 1.4; p < 0.001). The HEC test demonstrated a sensitivity of 94%, specificity of 88%, and an AUC of 0.99, with a high cutoff (VAS score reduction of 5) outperforming conventional tests. Three tests-including the HEC test, resisted hip flexion (seated), and resisted hip external rotation (seated)-met all three criteria to be classified as "good" tests, whereas the Thomas test, SLR in neutral, and the snapping hip test were deemed "poor" tests. The HEC test was ranked best to detect iliopsoas tendinopathy, followed by the resisted hip flexion (seated), SLR in exorotation, and resisted hip external rotation (seated). CONCLUSION: The HEC test is an accurate diagnostic maneuver for iliopsoas tendinopathy offering improved sensitivity and specificity compared with conventional tests. Surgeons should consider incorporating the HEC test into routine evaluations of patients with groin pain to enhance diagnostic precision and optimize treatment strategies. Future studies should focus on interobserver reliability and assess the test's performance across diverse patient populations. LEVEL OF EVIDENCE: Level III, diagnostic study.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Vandeputte FJ, Driesen R, Timmermans A, et al. Evaluation of Clinical Tests to Diagnose Iliopsoas Tendinopathy. Clin Orthop Relat Res. 2025. PMID: 40388705. doi:10.1097/CORR.0000000000003520

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。